Welcome Letter From John 
Welcome to the CIG website. We are glad that you found us, and trust that you will find the information presented useful, whether you are a newly diagnosed patient, or an experienced one. In the world of non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are often under represented. In order to gather more information, patients who have become affected by this blood disorder need to group together and become more “visible” and vocal in the medical community. As a collective group, we’ll be in a better position to raise CLL/SLL awareness and better request resources dedicated to our needs.
New This Month
New CLL Publication Released - Download or Order Today
CIG is pleased to announce the availability of the first edition of Understanding CLL/SLL: A Guide for Patients, Survivors and Loved Ones. Download the PDF or order a copy online.
FDA Approves Rituximab (Rituxan) Plus Chemotherapy for CLL
Read about the FDA approval of rituximab (Rituxan) in combination with fludarabine and cyclophosphamide for patients with untreated or previously treated CD20-positive chronic lymphocytic leukemia.
CIG Website Updated
CIG is pleased to announce that the About CLL/SLL, Treatments, Complications and Latest Research sections of the website have new content.
Lymphoma Workshop - Scottsdale, Arizona
On Saturday, March 6, 2010, CIG will host two special breakout sessions on CLL/SLL at this full day educational program for patients and survivors. Register today!
Lymphoma Workshop - Needham, Massachusetts
On Saturday, April 17, 2010, CIG will host a special breakout session on CLL/SLL at this full day educational program for patients and survivors. Register today!
Lymphoma Workshop - Chicago, Illinois
On Saturday, May 22, 2010, CIG will host two special breakout sessions on CLL/SLL at this full day educational program for patients and survivors. Register today!
New Online Resource for CLL Patients and Survivors
View this free webcast program today.
New This Month Archive
Subscribe to CLL/SLL Discussion Group
CIG is not a discussion group; it is a patient advocacy group that dispenses disease-specific information to people with CLL/SLL and their loved ones. However, we do have a related group where frequent and interesting discussions do take place. Richard Furman, MD, a CLL expert from Weill Medical College of Cornell University and New York-Presbyterian, is now active on this discussion group, so we have an important medical advisor on board. Subscribe to the discussion group today.
Join CIG
To receive regular updates from us about new content, news, and upcoming programs and events, please Join CIG.
back to top
